| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jamie O Lo, Jason C Hedges, Guillermina Girard. Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes. American journal of obstetrics and gynecology. 2022-06-06. PMID:35662548. |
the biological effects of cannabis are mediated by the endocannabinoid system and studies have reported the presence of cannabinoid receptors in the male and female reproductive tract, on sperm and the placenta, suggesting the endocannabinoid system plays a role in regulating reproduction. |
2022-06-06 |
2023-08-14 |
human |
| Eef Lien Theunissen, Kim Paula Colette Kuypers, Natasha Leigh Mason, Johannes Gerardus Ramaeker. A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence. Frontiers in psychiatry. vol 13. 2022-06-06. PMID:35664482. |
a comparison of acute neurocognitive and psychotomimetic effects of a synthetic cannabinoid and natural cannabis at psychotropic dose equivalence. |
2022-06-06 |
2023-08-14 |
human |
| Eef Lien Theunissen, Kim Paula Colette Kuypers, Natasha Leigh Mason, Johannes Gerardus Ramaeker. A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence. Frontiers in psychiatry. vol 13. 2022-06-06. PMID:35664482. |
due to differences in potency, efficacy, and affinity for cb1 receptors, similarities and differences in psychoactive effect profiles of natural cannabis and synthetic cannabinoids (scs) cannot reliably be derived from equipotent dose comparisons. |
2022-06-06 |
2023-08-14 |
human |
| Alessandra Manca, Alice Palermiti, Jacopo Mula, Elisa Delia De Vivo, Sandra Zeaiter, Marco Simiele, Amedeo De Nicolò, Marco Cantù, Jessica Cusato, Antonio D'Avoli. A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 102. 2022-06-06. PMID:35665680. |
a description of cannabinoid levels in cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of north-italy. |
2022-06-06 |
2023-08-14 |
Not clear |
| Nirupa J Raghunathan, Jessica Brens, Swetha Vemuri, Qing S Li, Jun J Mao, Deborah Korenstei. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022-06-06. PMID:35665859. |
cannabis products, including the cannabinoids cbd and thc, are rising in popularity and increasingly used for medical purposes. |
2022-06-06 |
2023-08-14 |
Not clear |
| Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska, Zecharia Mada. THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet. Journal of cannabis research. vol 4. issue 1. 2022-06-01. PMID:35644678. |
in this study, we evaluated the therapeutic effects of the two major cannabinoids, delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd), on nafld progression. |
2022-06-01 |
2023-08-13 |
mouse |
| Danielle McCartney, Anastasia S Suraev, Peter T Doohan, Christopher Irwin, Richard C Kevin, Ronald R Grunstein, Camilla M Hoyos, Iain S McGrego. Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial. Journal of psychopharmacology (Oxford, England). 2022-05-31. PMID:35637624. |
cannabidiol (cbd), a major cannabinoid of |
2022-05-31 |
2023-08-13 |
Not clear |
| Blessing N Marandure, Samson Mhizha, Amanda Wilso. " Journal of psychoactive drugs. 2022-05-31. PMID:35640052. |
" synthetic cannabinoids (sc) are the most common type of new psychoactive substances used predominantly as a replacement for cannabis. |
2022-05-31 |
2023-08-13 |
Not clear |
| Fabrizio Calapai, Luigi Cardia, Gioacchino Calapai, Debora Di Mauro, Fabio Trimarchi, Ilaria Ammendolia, Carmen Mannucc. Effects of Cannabidiol on Locomotor Activity. Life (Basel, Switzerland). vol 12. issue 5. 2022-05-28. PMID:35629320. |
cannabidiol (cbd) is the second cannabinoid, in order of importance after Δ9-tetrahydrocannabinol (thc), from |
2022-05-28 |
2023-08-13 |
Not clear |
| Ute Mareck, Gregor Fusshöller, Thomas Schertel, Simon Petring, Marilyn A Huestis, Mario Thevi. Risk of unintentional antidoping rule violations by consumption of hemp products. Drug testing and analysis. 2022-05-28. PMID:35633098. |
hemp products are prepared from cannabis plants and, therefore, might contain a variety of different natural cannabinoids. |
2022-05-28 |
2023-08-13 |
Not clear |
| Ute Mareck, Gregor Fusshöller, Thomas Schertel, Simon Petring, Marilyn A Huestis, Mario Thevi. Risk of unintentional antidoping rule violations by consumption of hemp products. Drug testing and analysis. 2022-05-28. PMID:35633098. |
according to the regulations of the world anti-doping agency (wada), all natural and synthetic cannabinoids are prohibited in-competition, with the explicit exemption of cannabidiol (cbd). |
2022-05-28 |
2023-08-13 |
Not clear |
| Divya Vimal, Leonard Clinton D'Souza, Vipin Rai, Samridhi Lal, Anurag Sharma, Subash Chandra Gupt. Efficacy of cannabis and its constituents in disease management: Insights from clinical studies. Current medicinal chemistry. 2022-05-27. PMID:35619266. |
among over 500 identified compounds (cannabinoids), Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd) are two major active cannabinoids derived from cannabis. |
2022-05-27 |
2023-08-13 |
human |
| Divya Vimal, Leonard Clinton D'Souza, Vipin Rai, Samridhi Lal, Anurag Sharma, Subash Chandra Gupt. Efficacy of cannabis and its constituents in disease management: Insights from clinical studies. Current medicinal chemistry. 2022-05-27. PMID:35619266. |
in the recent past, clinical trials have shown the efficacy of cannabis and cannabinoids for various human ailments such as cancer, neurological disorders, inflammatory bowel disease, chronic pain, and metabolic disorders. |
2022-05-27 |
2023-08-13 |
human |
| Stephanie Bourke, Anne Katrin Schlag, Saoirse Elizabeth O'Sullivan, David J Nutt, David P Fin. Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research. Pharmacology & therapeutics. 2022-05-24. PMID:35609718. |
single entity cannabinoids, cannabis, and cannabis-based medicines in patients with fm show promise therapeutically but limitations in methodology and lack of longitudinal studies to assess efficacy and tolerability preclude the current recommendation for their use in patients with fm. |
2022-05-24 |
2023-08-13 |
Not clear |
| Jeremy Y Ng, Nathan Chan. A bibliometric analysis of the cannabis and cannabinoid research literature. Journal of cannabis research. vol 4. issue 1. 2022-05-24. PMID:35610633. |
a bibliometric analysis of the cannabis and cannabinoid research literature. |
2022-05-24 |
2023-08-13 |
Not clear |
| Jeremy Y Ng, Nathan Chan. A bibliometric analysis of the cannabis and cannabinoid research literature. Journal of cannabis research. vol 4. issue 1. 2022-05-24. PMID:35610633. |
the present bibliometric analysis aims to capture the characteristics of scholarly journal publications on the topic of cannabis and cannabinoid research. |
2022-05-24 |
2023-08-13 |
Not clear |
| Christiana J Smith, Daniela Vergara, Brian Keegan, Nick Jikome. The phytochemical diversity of commercial Cannabis in the United States. PloS one. vol 17. issue 5. 2022-05-19. PMID:35588111. |
we analyzed the cannabinoid and terpene content of commercial cannabis samples across six us states, finding distinct chemical phenotypes (chemotypes) which are reliably present. |
2022-05-19 |
2023-08-13 |
human |
| Clémence Lacroix, Isabelle Alleman-Brimault, Arnaud Zalta, Frank Rouby, Catherine Cassé-Perrot, Elisabeth Jouve, Laurence Attolini, Romain Guilhaumou, Joëlle Micallef, Olivier Bli. What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps? Frontiers in pharmacology. vol 13. 2022-05-16. PMID:35571129. |
as we know that the endocannabinoid system is largely involved in neurological disorders, we focused on the scientific rationale of medical cannabis in three neurological disorders: amyotrophic lateral sclerosis, parkinson's disease, and alzheimer's disease through pharmacological plausibility, clinical studies, and patients' view. |
2022-05-16 |
2023-08-13 |
Not clear |
| Sterling C Torian, Lisa Hayes, Ana Negret. Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids: A case report. The American journal of emergency medicine. 2022-05-16. PMID:35577625. |
obtaining factor levels in patients with an unexplained coagulopathy and suspected cannabis or synthetic cannabinoid use may aid clinicians in a more prompt diagnosis and treatment. |
2022-05-16 |
2023-08-13 |
Not clear |
| Riccardo Deidda, Amandine Dispas, Charlotte De Bleye, Philippe Hubert, Éric Ziemon. Critical review on recent trends in cannabinoid determination on cannabis herbal samples: From chromatographic to vibrational spectroscopic techniques. Analytica chimica acta. vol 1209. 2022-05-15. PMID:35569861. |
critical review on recent trends in cannabinoid determination on cannabis herbal samples: from chromatographic to vibrational spectroscopic techniques. |
2022-05-15 |
2023-08-13 |
Not clear |